Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2012
09/12/2012CN102659921A HLA-A*0201 restrictive CTL epitope of neuritin protein, and application of HLA-A*0201 restrictive CTL epitope
09/12/2012CN101891800B Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof
09/11/2012US8263738 Estrogen receptors and methods of use
09/11/2012US8263561 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
09/11/2012CA2465245C Biologically active peptides and their use for repairing injured nerves
09/07/2012WO2012118972A2 Process of preparing guanylate cyclase c agonists
09/07/2012WO2012118778A1 Truncated car peptides and methods and compositions using truncated car peptides
09/07/2012WO2012118444A1 Novel compounds with photoluminescnce properties and applications thereof
09/07/2012WO2012118353A2 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012118070A1 Anti-gram-negative bacteria agent
09/07/2012WO2012038932A3 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
09/07/2012CA2828346A1 Process of preparing guanylate cyclase c agonists
09/06/2012US20120226018 Process for the Synthesis of Ac-Arg-Cyclo(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH2
09/06/2012US20120225831 Melanocortin-1 Receptor-Specific Linear Peptides
09/06/2012US20120225828 Melanocortin-1 Receptor-Specific Cyclic Peptides
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225822 Peptides for the treatment of oxidative stress related disorders
09/06/2012US20120225821 Composition for preventing or treating a spinal cord injury
09/06/2012US20120225820 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis
09/06/2012US20120225809 Compounds for treating papilloma virus infection
09/06/2012US20120225078 Immune system modulating composition
09/06/2012US20120225023 Peptide protection against ultraviolet light toxicity
09/05/2012EP2493843A1 2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides such as bacitracins
09/05/2012EP2493493A1 New bacitracin antibiotics
09/05/2012CN1961001B Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
09/05/2012CN1956994B Epithelial cell growth promoter
09/05/2012CN1639569B Methods and compositions for inducing an immune response
09/05/2012CN102656186A Therapeutic agents
09/05/2012CN102656183A 催产素受体激动剂 Oxytocin receptor agonist
09/05/2012CN102655874A Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
09/05/2012CN102653555A Method for preparing goserelin by solid phase
09/05/2012CN102653554A Functional mycobacterium tuberculosis antigen polypeptide and application thereof
09/05/2012CN102653553A Polypeptide having high affinity with beta clamp of mycobacterium tuberculosis
09/05/2012CN102653552A Serum polypeptide marker for chronic hepatitis b liver fibrosis and detection method thereof
09/05/2012CN102060913B Heptapeptide combined with human serum albumin and application thereof
09/05/2012CN101906140B Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof
09/05/2012CN101899091B Fatty alkyl pentapeptide conjugate, preparation method thereof and application thereof in medical science
09/05/2012CN101891803B New cartilaginous affinity polypeptide sequence, screening method and application thereof
09/05/2012CN101891801B Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof
09/05/2012CN101838313B Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101838312B Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101648994B Azepine argireline or pharmaceutically acceptable salt thereof and preparation method and application thereof
09/05/2012CN101627049B Synthetic peptide amides
09/05/2012CN101538316B Method for preparing Eptifibatide with solid phase method
09/05/2012CN101240032B Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
09/05/2012CN101168560B N-substituted peptide amide, pharmaceutical composition and use thereof
09/05/2012CN101076602B High-throughput enzyme-linked immuno absorbent assay (HT-ELISA) for determination of rho-kinase (ROK) activity
09/04/2012US8258261 Induction of tumor immunity by variants of folate binding protein
09/04/2012US8258259 Macromolecular compounds having controlled stoichiometry
09/04/2012US8258100 Ligand/lytic peptide methods of use
09/04/2012US8258099 Pin1-modulating compounds and methods of use thereof
09/04/2012US8258096 Therapy procedure for drug delivery for trigeminal pain
09/04/2012US8257711 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
08/2012
08/30/2012WO2012115159A1 Polypeptide compound
08/30/2012WO2012115118A1 Polypeptide compound
08/30/2012WO2012113803A1 A cyclic peptide and conjugate thereof for binding to keratinocytes
08/30/2012US20120220720 Functionalized cell binding peptides and cell culture articles
08/30/2012US20120220539 Conotoxin peptides
08/30/2012US20120220537 9-aminoacridine derivatives, their preparation and uses
08/30/2012US20120220535 Cyclic-glur6 analogs, methods of treatment and use
08/30/2012US20120220526 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and other Disorders
08/30/2012US20120220525 Stablized Melanocortin Ligands
08/30/2012US20120220519 Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses
08/30/2012US20120220490 Method and compositions for detecting botulinum neurotoxin
08/30/2012US20120219977 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
08/30/2012US20120219972 Diagnosis and treatment of ehrlichiosis
08/30/2012US20120219574 Antigen surrogates in autoimmune disease
08/30/2012US20120219505 Peptide reagents and methods for detection of colon dysplasia
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/29/2012EP2491052A2 Oxytocin receptor agonists
08/29/2012EP2008664B1 Modified proteins which bind extracellular matrix components
08/29/2012CN102649817A Monoclonal antibody for inhibiting formation of bacterial biofilm
08/29/2012CN102212109B Bone polypeptide compound separated from ossotide injection and application thereof
08/29/2012CN101948510B Molecular mimic peptide of type O foot and mouth disease virus VP2 epitope and applications thereof
08/29/2012CN101426807B Neuroprotective compounds and uses thereof
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252907 Methods and compositions for inhibiting binding of IgE to a high affinity receptor
08/28/2012US8252896 Process for making bivalirudin
08/28/2012US8252895 Cyclic peptide compounds
08/28/2012US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/28/2012US8252745 Methods for treatment of headaches by administration of oxytocin
08/28/2012US8252740 Thermally-targeted delivery of medicaments including doxorubicin
08/28/2012US8252338 Synthetic LDL as targeted drug delivery vehicle
08/28/2012CA2657476C Protein-binding methotrexate derivatives and medicaments containing the same
08/28/2012CA2412531C Antimicrobial peptides and methods of use thereof
08/23/2012WO2012112767A2 Collagen-targeted nanoparticles
08/23/2012WO2012111438A1 Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same
08/23/2012WO2012110636A2 Carrier peptides for cell delivery
08/23/2012WO2012109735A1 Methods of preparing cyclic amino acid molecules using arylboronic or arylborinic acid catalysts
08/23/2012WO2011095768A8 Lantibiotic salts
08/23/2012US20120214969 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
08/23/2012US20120214968 Preparation of phalloidin and its derivatives
08/23/2012US20120214967 Cross-linked glycopeptide-cephalosporin antibiotics
08/23/2012US20120214750 Crystalline form of linaclotide
08/23/2012US20120214748 Novel peptides, process for preparation thereof, and use thereof
08/23/2012US20120214745 Deuterated Cyclosporine Analogs and Methods of Making the Same
08/23/2012US20120214742 Gaba release-regulating agent in cerebellum
08/23/2012US20120214741 Vdac1 compositions and methods of use thereof for regulating apoptosis
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 423